rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

Clinical trial NCT01525836 · COMPLETED

Trial details

NCT number: NCT01525836
Sponsor: Shandong University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura Idiopathic Thrombocytopenic Purpura

Start date: 2011-05-01
Primary completion: 2013-12-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.